ERCC1 and cervical carcinoma: There was a significant correlation between ERCC1 mRNA expression and cisplatin resistance in all cervical carcinoma lines (all P< 0.05), but such an association was not significant in ERCC1 protein expression (all P>0.05). It might be possible to identify cervical tumors likely to be resistant to cisplatin by examining pre-treatment ERCC1 mRNA levels.